Literature DB >> 20535241

Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.

Beth D Kennard1, Sunita M Stewart, Jennifer L Hughes, Robin B Jarrett, Graham J Emslie.   

Abstract

Relapse rates for children and adolescents with major depressive disorder (MDD) range from 30% to 40% within 1 to 2 years after acute treatment. Although relapse rates are high, there have been relatively few studies on the prevention of relapse in youth. While acute phase pharmacotherapy has been shown to reduce symptoms rapidly in depressed youth, children and adolescents frequently report ongoing residual symptoms and often relapse following acute treatment. Recent adult trials have begun examining augmentation with psychosocial treatment after successful medication treatment to enhance medication response and prevent future relapse. This strategy has not yet been examined in youth with depression. Here we present initial efforts to develop a sequential, combination treatment strategy to promoting rapid remission and to prevent relapse in depressed youth. We describe efforts to adapt CBT to prevent relapse (RP-CBT) in youth who respond to pharmacotherapy. The goals of RP-CBT include: preventing relapse, increasing wellness, and developing skills to promote and sustain a healthy emotional lifestyle. We describe the rationale for, components of, and methods used to develop RP-CBT. The results from a small open series sample demonstrate feasibility and indicate that youth appear to tolerate RP-CBT well. A future test of the treatment in a randomized controlled trial is described.

Entities:  

Year:  2008        PMID: 20535241      PMCID: PMC2882305          DOI: 10.1016/j.cbpra.2008.02.006

Source DB:  PubMed          Journal:  Cogn Behav Pract        ISSN: 1077-7229


  61 in total

Review 1.  Remission versus response: the new gold standard of antidepressant care.

Authors:  Martin B Keller
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

2.  Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder.

Authors:  B Birmaher; D A Brent; D Kolko; M Baugher; J Bridge; D Holder; S Iyengar; R E Ulloa
Journal:  Arch Gen Psychiatry       Date:  2000-01

3.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.

Authors:  D A Brent; D Holder; D Kolko; B Birmaher; M Baugher; C Roth; S Iyengar; B A Johnson
Journal:  Arch Gen Psychiatry       Date:  1997-09

4.  Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders.

Authors:  G A Fava; C Rafanelli; M Cazzaro; S Conti; S Grandi
Journal:  Psychol Med       Date:  1998-03       Impact factor: 7.723

5.  Efficacy of interpersonal psychotherapy for depressed adolescents.

Authors:  L Mufson; M M Weissman; D Moreau; R Garfinkel
Journal:  Arch Gen Psychiatry       Date:  1999-06

6.  Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Todd W Dunn; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2007-06

7.  Acute time to response in the Treatment for Adolescents with Depression Study (TADS).

Authors:  Christopher Kratochvil; Graham Emslie; Susan Silva; Steve McNulty; John Walkup; John Curry; Mark Reinecke; Benedetto Vitiello; Paul Rohde; Nora Feeny; Charles Casat; Sanjeev Pathak; Elizabeth Weller; Diane May; Taryn Mayes; Michele Robins; John March
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 8.829

8.  Effects of perceived stress on pediatric chronic pain.

Authors:  J W Varni; M A Rapoff; S A Waldron; R A Gragg; B H Bernstein; C B Lindsley
Journal:  J Behav Med       Date:  1996-12

9.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

10.  Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

View more
  4 in total

1.  Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.

Authors:  Jeffrey R Strawn; Jeffrey A Mills; Paul E Croarkin
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-02-27       Impact factor: 2.576

2.  Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.

Authors:  Betsy D Kennard; Graham J Emslie; Taryn L Mayes; Jeanne Nightingale-Teresi; Paul A Nakonezny; Jennifer L Hughes; Jessica M Jones; Rongrong Tao; Sunita M Stewart; Robin B Jarrett
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 8.829

3.  Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?

Authors:  Elizabeth E Hathaway; John T Walkup; Jeffrey R Strawn
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2018-01-12

4.  A next-generation social media-based relapse prevention intervention for youth depression: Qualitative data on user experience outcomes for social networking, safety, and clinical benefit.

Authors:  Olga Santesteban-Echarri; Simon Rice; Greg Wadley; Reeva Lederman; Simon D'Alfonso; Penni Russon; Richard Chambers; Christopher J Miles; Tamsyn Gilbertson; John F Gleeson; Patrick D McGorry; Mario Álvarez-Jiménez
Journal:  Internet Interv       Date:  2017-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.